Management of Periprosthetic Joint Infection

Thứ bảy - 30/12/2017 21:47
Periprosthetic joint infection (PJI) is among the most serious complications in the field of endoprosthetics. The number of PJIs is increasing worldwide and poses a real interdisciplinary challenge for everyone involved
Management of Periprosthetic Joint Infection
Management of Periprosthetic Joint Infection

Management of Periprosthetic Joint Infection

Periprosthetic joint infection (PJI) is among the most serious complications in the field of endoprosthetics. The number of PJIs is increasing worldwide and poses a real interdisciplinary challenge for everyone involved. For the patient concerned, it is necessary to promptly work out an adequate therapy solution to fight off the infection. Both the clinical experience of the surgeon and the proper diagnostic processes are prerequisite for the reliable detection and identification of an infection. The microbiologist is responsible for identifying the causative germs by screening the patient’s synovial fluid and tissue samples. Based on the findings and subsequent resistance testing, the infectious disease specialist can recommend the appropriate antibiotic therapy. 

Management of Periprosthetic Joint Infection

Furthermore, the clinical pharmacist is consulted regularly throughout the therapy to discuss the risk of potential drug interactions. The surgeon will proceed with the revision surgery, following defined algorithms. Adequate radical debridement of infected and necrotic surrounding tissue is the most important step towards a successful cure of the infection. Accompanying the surgery, anti-infective agents are given systemically and locally. While systemic application of anti-infectives mainly reduces the number of haematogenic-spreading planktonic germs, local application immediately forms a colonization barrier and protects the implant from sessile biofilm formation. Concurrently, antibiotics are actively released from the implant, resulting in local germ reduction. 

Management of Periprosthetic Joint Infection

Thus, local agents are embedded in the concept of surgical PJI treatment as a reliable adjuvant measure and they sustainably support the successful outcome. In one-stage procedures, local agents are released from specialized antibiotic-loaded bone cements, while in two- or multi-stage procedures, local agents are released from corresponding temporary spacers (interim prostheses). Even from an economic standpoint, the combination of systemic and local agent application is meaningful. Furthermore, there are some interesting trends towards the coating of metallic implants to protect against biofilm formation on the implant surface. 

Management of Periprosthetic Joint Infection

Management of Periprosthetic Joint Infection: A global perspective on diagnosis, treatment options, prevention strategies and their economic impact by Klaus-Dieter Kühn
English | 3 Nov. 2017 | ISBN: 3662544687 | 366 Pages | PDF | 10.21 MB
 Từ khóa: Management

Tổng số điểm của bài viết là: 0 trong 0 đánh giá

Click để đánh giá bài viết

  Ý kiến bạn đọc

Làm gì khi bị bệnh gan nhiễm mỡ?

Làm gì khi bị bệnh gan nhiễm mỡ? Điều trị chính cho bệnh gan nhiễm mỡ bao gồm thay đổi chế độ ăn và tập thể dục, mặc dù một số người có thể cần phải đi khám bác sĩ để điều trị thêm. Cơ thể dự trữ mỡ ở nhiều nơi để cung cấp năng lượng và giữ ấm. Gan có cấu tạo một phần là mỡ, nhưng nếu lượng mỡ...

Thăm dò ý kiến

Bạn thích gì ở sách Việt?

Bạn đã không sử dụng Site, Bấm vào đây để duy trì trạng thái đăng nhập. Thời gian chờ: 60 giây